Omalizumab and Churg-Strauss syndrome

A. M. Ruppert, D. Stanciu, G. Averous, S. Riehm, C. Debry, F. De Blay (Strasbourg, France)

Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Session: Improving asthma therapy - new findings in established and experimental treatment modalities
Session type: Thematic Poster Session
Number: 3641
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Ruppert, D. Stanciu, G. Averous, S. Riehm, C. Debry, F. De Blay (Strasbourg, France). Omalizumab and Churg-Strauss syndrome. Eur Respir J 2007; 30: Suppl. 51, 3641

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An intergrated approach to Churg-Strauss syndrome
Source: Annual Congress 2009 - Update on eosinophilic lung diseases
Year: 2009


Churg-Strauss's syndrome and eosinophilic polyserositis
Source: Eur Respir J 2002; 20: Suppl. 38, 65s
Year: 2002

Good tolerance of aspirin in Churg-Strauss syndrome
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008


The basis of Churg-Strauss syndrome diagnosis in own material
Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases
Year: 2010

Airway and systemic inflammation during Churg-Strauss syndrome natural course
Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways
Year: 2012

Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69
Year: 2005

Anca and anti-gbm-antibodies in pulmonary-renal syndrome due to Wegener‘s granulomatosis
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?
Source: Eur Respir J 2015; 46: 1255-1258
Year: 2015


Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
Source: ERJ Open Res, 6 (4) 00339-2020; 10.1183/23120541.00339-2020
Year: 2020



Long-term follow-up in Churg-Strauss syndrome following IFN-α-induced remission
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012


Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021


Heart involvement in Churg-Strauss syndrome (CSS)
Source: Eur Respir J 2006; 28: Suppl. 50, 384s
Year: 2006

Etanercept-induced pleuropericardial lupus-like syndrome
Source: Eur Respir J 2009; 33: 939-941
Year: 2009


BOOP as presenting manifestation of idiopathic hyper-eosinophilic syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 375s
Year: 2005

Tacrolimus for antisynthetase syndrome with interstitial lung disease?
Source: Eur Respir J 2008; 32: 244-245
Year: 2008


Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis
Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020
Year: 2020



New therapy for pulmonary-renal Goodpasture‘s syndrome
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Severe persistent asthma in children with Ehlers-Danlos’ syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Successive treatment of Churg-Strauss syndrome with cyclesonide after oral steroids discontinuation due to side effects
Source: Annual Congress 2008 - Rare clinical cases
Year: 2008